3rd Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 18, 2019 $50,000 Replaced
3rd Quarter - Amendment Mar 29, 2021 $50,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about the generic pharmaceutical industry.

Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.

LobbyistCovered position, as disclosed
MJ KENNY Deputy Floor Director, Floor Assistant - Office of the Senate Democratic Whip; Legislative Aide, Legislative Correspondent - Senator Richard J. Durbin (D-IL)
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to Medicaid CPI Penalty.

Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.

LobbyistCovered position, as disclosed
MJ KENNY —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to S.1895, the Lower Health Care Costs Act.

Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.

LobbyistCovered position, as disclosed
MJ KENNY —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1895 (116th)

Copyright/Patent/Trademark CPT

Issues related to the abuses of the patent system, extensions of drug exclusivity, pay-for-delay, and the inter partes review (IPR) process, including H. R. 1499, the Protecting Consumer Access to Generic Drugs Ace of 2019, and H. R. 938, the BLOCKING Act of 2019.

Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.

LobbyistCovered position, as disclosed
MJ KENNY —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1499 (116th), H.R. 938 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.